| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $456K | -59.2% |
| Cost of Revenue | $3.8M | — |
| R&D Expense | $5.3M | +33.5% |
| SG&A Expense | $29.7M | +68.6% |
| Operating Income | -$40.3M | -70.2% |
| Pre-tax Income | -$73.4M | -136.8% |
| Income Tax | -$3.3M | — |
| Net Income | -$61.8M | -100.2% |
| EPS (Basic) | -$1.41 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $283K | — |
| Inventory | $5.2M | — |
| Current Assets | $24.3M | +328.8% |
| Total Assets | $905.3M | +4098.1% |
| Current Liabilities | $69.3M | +749.0% |
| Long-term Debt | $13.7M | +43.0% |
| Total Liabilities | $139.0M | +372.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.2M | -50.0% |
| Capital Expenditures | $266K | -58.8% |
| Investing Cash Flow | $6.8M | +246.2% |
| Financing Cash Flow | $33.5M | +74.5% |
| Free Cash Flow | -$29.5M | -46.5% |
| — |
| EPS (Diluted) | -$1.41 | — |
| Stockholders' Equity |
| $425.5M |
| +2222.8% |